Valeant Pharmaceuticals Announces Approval of Retin-A Micro® Microsphere 0.08%

Valeant Pharmaceuticals International (NYSE: VRX ) announced today that it has received approval from the Food and Drug Administration (FDA) for its Supplemental New Drug Application (sNDA) for Retin-A Micro (tretinoin) Gel microsphere 0.08% for the topical treatment of acne vulgaris. "We are very pleased that the FDA has